Dermata Therapeutics

-$0.0496 (-6.70%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DRMA and other ETFs, options, and stocks.

About DRMA

Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company that focuses on identifying, developing and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin diseases. Its product pipeline includes DMT310, DMT400, and DMT410.

CEO
Gerald T. Proehl
Employees
8
Headquarters
San Diego, California
Founded
2014

DRMA Key Statistics

Market cap
6.37M
Price-Earnings ratio
—
Dividend yield
—
Average volume
31.33K
High today
$0.764
Low today
$0.65
Open price
$0.65
Volume
107.82K
52 Week high
$6.95
52 Week low
$0.62

DRMA Earnings

-$0.86
-$0.57
-$0.29
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.40 per share
Actual
-$0.33 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure